Another essential finding was the dual role of four biopsy-derived DVT-biomarkers (ABI3BP, IGKV2-40/IGKV2D-40, PCYOX1, and STIP1) in predicting poor healing outcomes, and were independent of age45. The gene discussed is STIP1; the disease is deep vein thrombosis.